Current position:Home >Product >
Piperidine, 1-[(E)-[2-(hexahydro-1H-azepin-1-yl)phenyl](hydroxyimino)methyl]-
Piperidine, 1-[(E)-[2-(hexahydro-1H-azepin-1-yl)phenyl](hydroxyimino)methyl]-(145090-54-6)
- Name: Piperidine, 1-[(E)-[2-(hexahydro-1H-azepin-1-yl)phenyl](hydroxyimino)methyl]-
- Synonyms:
- Molecular Formula:C18H27N3O
- Molecular Weight:301.432
- CAS Registry Number:145090-54-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 145070-48-0/Ethanone, 2-hydroxy-1-(2-methylphenyl)-
- 145070-49-1/1-Propanone, 1-(4-bromophenyl)-2-hydroxy-
- 145070-59-3/Benzene, 1-[(R)-[(1Z)-2-iodoethenyl]sulfinyl]-4-methyl-
- 145071-77-8/Benzene, 1-(cyclopentylmethyl)-4-nitro-
- 145081-02-3/2,7-Naphthalenedisulfonic acid, 5-[(2,6-difluoro-4-pyrimidinyl)amino]-4-hydroxy-3-[[1-sulfo-6-[[2-(sulfooxy )ethyl]sulfonyl]-2-naphthalenyl]azo]-
- 145083-23-4/Thiophene, tetrakis(1,1-dimethylethyl)-
- 145089-11-8/Acetic acid, [4-[[[(9H-fluoren-9-ylmethoxy)carbonyl]amino](4-methoxyphenyl)methyl]- 2-methylphenoxy]-
- 145089-12-9/L-Cysteine, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-S-(1,1- dimethylethyl)-
- 145089-13-0/L-Cysteine, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-S-(1,1- dimethylethyl)-, compd. with N-cyclohexylcyclohexanamine (1:1)
- 145089-14-1/L-Phenylalanine, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1)
- 145089-15-2/D-Phenylalanine, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-
- 145089-16-3/D-Phenylalanine, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1)
- 145089-17-4/L-Threonine, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-O-(1,1 -dimethylethyl)-
- 145089-18-5/L-Threonine, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-O-(1,1 -dimethylethyl)-, compd. with cyclohexanamine (1:1)
- 145089-19-6/D-Threonine, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-O-(1,1 -dimethylethyl)-
- 145089-20-9/D-Threonine, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-O-(1,1 -dimethylethyl)-, compd. with cyclohexanamine (1:1)
- 145089-21-0/D-Tryptophan, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-
- 145089-22-1/D-Tryptophan, N-[[1-[3,5-bis(1,1-dimethylethyl)phenyl]-1-methylethoxy]carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1)
- 145090-51-3/Piperidine, 1-[(E)-(hydroxyimino)[2-(1-piperidinyl)phenyl]methyl]-
- 145090-54-6/Piperidine, 1-[(E)-[2-(hexahydro-1H-azepin-1-yl)phenyl](hydroxyimino)methyl]-
- 145090-57-9/1H-Pyrido[1,2-a]quinazoline, 2,3,4,4a-tetrahydro-6-(1-piperidinyl)-, 5-oxide
- 145090-61-5/Azepino[1,2-a]quinazoline, 6a,7,8,9,10,11-hexahydro-5-(1-piperidinyl)-, 6-oxide
- 145091-16-3/1,4-Dioxaspiro[4.5]dec-6-ene-7-carboxylic acid, 8-oxo-, methyl ester
- 145091-64-1/Furan, 2-(1-hexenyl)-, (E)-
- 145092-00-8/1H-Pyrazol-3-ol, 5-amino-
- 145092-77-9/Bicyclo[2.2.1]heptane-2,5-dione, (1R,4R)-
- 1450-94-8/1-Methyl-1H-iMidazol-2-aMine hydrochloride
- 145099-30-5/2-Pyridinesulfonamide, N-[[(4-methoxy-6-methyl-2-pyrimidinyl)amino]carbonyl]-3-(2,2,2-trifluoro ethoxy)-
- 14510-12-4/L-Cysteine, S-(2-phenylethyl)-
- 145102-30-3/Cyclohexane, (cyclopentylideneiodomethyl)-